Literature DB >> 20504122

Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism.

Carlos A Feldstein1, Maia Akopian, Daniel Pietrobelli, Antonio Olivieri, Delia Garrido.   

Abstract

Our aims were to evaluate the prevalence and outcome of hypertension in patients with primary hyperparathyroidism (PHPT), previously and after follow-up of parathyroidectomy. A group of 46 consecutive patients with sporadic PHPT due to adenoma undergoing surgery were followed an average of 3.5 years (range 36 to 53 months). In 16 nonselected, consecutive parathyroidectomized patients, with normalized biochemical measurements, circadian rhythm of blood pressure was evaluated with ambulatory blood pressure monitoring (ABPM). Prevalence of hypertension in PHPT was 54.35%, and there was no significant association of PTH, total and ionic calcium levels with SBP and DBP. During follow-up, none of the patients with presurgical hypertension became normotensive and five of the normotensive patients developed clinical hypertension. In ABPM, 6/11 hypertensive and 3/5 normotensive subjects showed nondipper behavior. Serum total calcium was significantly related to night-time systolic blood pressure (SBP) (r = 0.620, P < 0.02), and night-time diastolic blood pressure (DBP) (r = 0.758, P < 0.002). In dippers, creatinine clearance was significantly higher (91.3 +/- 18.5 vs. 64.3 +/- 11.5 ml/min, P < 0.01), while serum total calcium was lower (2.42 +/- 0.13 vs. 2.23 +/- 0.17 mmol/L, P < 0.04) than in nondippers. In conclusion, our results suggest that parathyroidectomy has little effect on hypertension prevalence. Renal impairment, a condition that did not improve after parathyroidectomy, may be a causal factor of hypertension in PHPT. Also, the high prevalence of nondipper behavior in hypertensive and normotensive subjects after parathyroidectomy, suggests that target organ risk persists. We hypothesized that slight elevations of serum total calcium even in the normal range could be involved in the alteration of the circadian rhythm of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504122     DOI: 10.3109/10641960903254471

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  15 in total

1.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

2.  Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

Authors:  Adriana J van Ballegooijen; Marjolein Visser; Bryan Kestenbaum; David S Siscovick; Ian H de Boer; John S Gottdiener; Christopher R deFilippi; Ingeborg A Brouwer
Journal:  Am J Cardiol       Date:  2012-11-17       Impact factor: 2.778

3.  Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men.

Authors:  Emma O Billington; Greg D Gamble; Ian R Reid
Journal:  Bonekey Rep       Date:  2016-12-07

4.  Risk Factors for Intraoperative Hypertension during Surgery for Primary Hyperparathyroidism.

Authors:  Vera D Sabljak; Vladan R Zivaljevic; Biljana R Milicic; Ivan R Paunovic; Anka R Toskovic; Ksenija S Stevanovic; Katarina M Tausanovic; Dejan Z Markovic; Marina M Stojanovic; Mirko V Lakicevic; Milan D Jovanovic; Aleksandar D Diklic; Nevena K Kalezic
Journal:  Med Princ Pract       Date:  2017-04-10       Impact factor: 1.927

5.  Association of calcium concentration with pulse pressure in older women: data from a large population-based multicentric study.

Authors:  L Mateus-Hamdan; O Beauchet; Y Rolland; A-M Schott; C Annweiler
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

6.  Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.

Authors:  Andreas Tomaschitz; Astrid Fahrleitner-Pammer; Burkert Pieske; Nicolas Verheyen; Karin Amrein; Eberhard Ritz; Katharina Kienreich; Jörg H Horina; Albrecht Schmidt; Elisabeth Kraigher-Krainer; Caterina Colantonio; Andreas Meinitzer; Stefan Pilz
Journal:  BMC Endocr Disord       Date:  2012-09-13       Impact factor: 2.763

7.  Hypertension Secondary to PHPT: Cause or Coincidence?

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Int J Endocrinol       Date:  2011-03-07       Impact factor: 3.257

8.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

9.  Radiological imaging in endocrine hypertension.

Authors:  Chandan J Das; Manash P Baruah; Upasana M Baruah
Journal:  Indian J Endocrinol Metab       Date:  2011-10

10.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.